Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Thrombosis 1Thromboembolism 1Sarcoma, Alveolar Soft Part 1Prostatic Neoplasms 1Embolism and Thrombosis 1Embolism 1

Interventions

Warfarin 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Embolism × Warfarin × Clear all
NCT00216866 2017-08-28

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Completed
70 enrolled

Embolism, Thrombosis, Embolism and Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡